Cyxone Ab Stock Profit Margin
| CYXO Stock | SEK 0.03 0 11.11% |
Cyxone AB fundamentals help investors to digest information that contributes to Cyxone AB's financial success or failures. It also enables traders to predict the movement of Cyxone Stock. The fundamental analysis module provides a way to measure Cyxone AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cyxone AB stock.
Cyxone |
Cyxone AB Company Profit Margin Analysis
Cyxone AB's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Cyxone AB has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The profit margin for all Sweden stocks is 100.0% lower than that of the firm.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Cyxone Fundamentals
| Return On Equity | -1.07 | |||
| Return On Asset | -0.59 | |||
| Current Valuation | 7.74 M | |||
| Shares Outstanding | 98.44 M | |||
| Shares Owned By Insiders | 25.38 % | |||
| Price To Book | 1.00 X | |||
| Price To Sales | 5,168 X | |||
| EBITDA | (43.23 M) | |||
| Net Income | (45.03 M) | |||
| Cash And Equivalents | 56.34 M | |||
| Cash Per Share | 0.97 X | |||
| Current Ratio | 11.35 X | |||
| Book Value Per Share | 0.50 X | |||
| Cash Flow From Operations | (43.25 M) | |||
| Earnings Per Share | (0.76) X | |||
| Target Price | 4.2 | |||
| Beta | 0.54 | |||
| Market Capitalization | 52.96 M | |||
| Total Asset | 46.13 M | |||
| Net Asset | 46.13 M |
About Cyxone AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cyxone AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cyxone AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cyxone AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cyxone Stock Analysis
When running Cyxone AB's price analysis, check to measure Cyxone AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyxone AB is operating at the current time. Most of Cyxone AB's value examination focuses on studying past and present price action to predict the probability of Cyxone AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyxone AB's price. Additionally, you may evaluate how the addition of Cyxone AB to your portfolios can decrease your overall portfolio volatility.